Experiment 1151971
Worktypes
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | IV |
| Organism | Empty organism |
| Citation | RAUWS,AG: OLLING,M: TIMMERMAN,A:. (1982). THE PHARMACOKINETICS OF AMYGDALIN.. 49(3/4) |
| Amount utilized | |
| Compound isolated | |
| Disease | THE ALPHA AND BETA HALF LIVES WERE 0.10 AND 0.57 H, RESPECTIVELY. THE VOLUME OF DISTRIBUTION OF THE CENTRAL COMPARTMENT WAS 0.20 1/KG AND THE VOLUME OF DISTRIBUTION OF THE BETA PHASE OR ELIMINATION PHASE WAS 0.30 1/KG. |
| Dose amount | 50.0 MG |
| Number | 1 |
| Qualitative result | ACTIVE |
| Animal | DOG |
| Per unit | KG |
| Dose expression | DOSE |